It is further tempting to speculate on a potential role of oncogenic CCR7 mutations in EBV + DLBCL (NOS), prompting cellular proliferation and migration upon the binding of the cognate chemokine receptors, as was recently shown in breast cancer and other solid tumors53. The gene discussed is CCR7; the disease is breast cancer.